- $104.63m
- $94.67m
- $42.20m
- 45
- 26
- 25
- 22
Annual income statement for XCHG, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 20-F |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 13.2 | 29.4 | 38.5 | 42.2 |
| Cost of Revenue | ||||
| Gross Profit | 4.78 | 10.7 | 17.7 | 21.2 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Depreciation and Amortization | ||||
| Unusual Expense / Income | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 15.1 | 27.8 | 45 | 54 |
| Operating Profit | -1.93 | 1.65 | -6.52 | -11.8 |
| Total Net Non Operating Interest Income / Expense | ||||
| Net Income Before Taxes | -2.07 | 1.6 | -8.08 | -11.9 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -2.07 | 1.61 | -8.08 | -11.9 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -2.07 | 1.61 | -8.08 | -11.9 |
| Adjustments to Net Income | ||||
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -2.07 | 0.028 | -10.5 | -13.1 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.001 | 0 | -0.004 | -0.01 |